Avenzo Therapeutics

Avenzo Therapeutics is a clinical-stage biotechnology company co-founded by Dr. Athena Countouriotis and Dr. Mohammad Hirmand in 2022. The company is building and advancing a portfolio of potential first-in-class oncology therapies that target cell cycle control to prevent the abnormal cell proliferation responsible for many cancers.